Insights into cancer: from inflammation to Tumor
The adventure begins SiRIC InsiTu !
InsiTu is one of the 8 SiRICs (Integrated Cancer Research Centers) accredited in 2023, for a period of 5 years. It is based mainly on 2 research centers: the Inflammation Research Center (CRI) and the Saint-Louis Research Institute (IRSL), in close collaboration with the AP-HP.Nord hospitals (Beaujon/Bichat and Saint-Louis) and the AP-HP.Nord Cancer Institute (Université Paris Cité).
Its objectives? PreventIntercept, Cure! Identify individuals at risk, Prevent the development of cancer in them, Develop innovative therapies to effectively treat patients already affected.
Many CRI members are part of this adventure:
V. Paradis, S. Lotersztajn, H. Gilgenkrantz, R. Sinkus, E. Viennois, A. Couvineau, J. Cros, C. Haumaitre, P. Garteiser, B. Van Beers, R. Nicolle, L. Saveanu, B. Crestani.
Congratulations on the dynamic and in particular to V Paradis, who came up with the idea!
Find out more on : SIRIC InsiTu
